The European clinical trials landscape is undergoing a massive transformation. Driven by the unified European Medicines Agency (EMA) Clinical Trials Regulation (CTR) and an industry-wide shift toward decentralized methodologies, the criteria for running a successful study have evolved.
Within this environment, Greece has emerged as a key destination for international life sciences investments....
The global life sciences sector is expanding rapidly, and Greece has emerged as a premier hub for clinical research within the European Union. Boasting an exceptional network of medical professionals, high-performing investigative sites, and centralized healthcare infrastructure, the region offers immense potential for international sponsors. However, establishing or scaling operations here...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
